Tumor cells can maintain their growth via immunosuppression and escape from host antitumor immunity by controlling the PD-1/PD-L1 system. Expression of PD-L1 (CD274) is an inhibitory signal for T cells, while the increase in CD326 expression in the tumor tissue correlates with metastasis development. The experimental preparation on the basis of α(1,2)-L-rhamno-α(1,4)-D-galactopyranosyluronan from Acorus calamus L. produces an antitumor effect: it reduces tumor node size and the number and area of metastases after transplantation of Lewis lung carcinoma. Using flow cytometry, we demonstrated a decrease in the population of tumor cells expressing surface CD274 (PD-L1) and CD326 antigens after 20-day course of α(1,2)-L-rhamno-α(1,4)-D-galactopyranosyluronan.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Zueva EP, Lopatina KA, Razina TG, Gur’ev AM. Polysaccharides in Oncology. Tomsk, 2010. Russian.
Lakin GF. Biometry. Moscow, 1990. Russian.
Lemeshko BYu, Lemeshko SB. Power and robustness of criteria used to verify the homogeneity of means. Measurement Techniques. 2008;51(9):950-959.
Lopatina KA, Razina TG, Zueva EP, Krylova SG, Guryev AM, Amosova EN, Rybalkina OY, Safonova EA, Efimova LA, Belousov MV. Preclinical studies of α(1,2)-L-RAMNO-α(1,4)-Dgalactopiranoziluronan from rhizomes Аcorus calamus L. in cancer experiment. Sib. Onkol. Zh. 2015;(1):59-63. Russian.
Moiseenko VM, Volkov NM. The most important events in oncology in 2014: immunotherapy of malignant neoplasms. Prakt. Onkol. 2015;16(1):6-12. Russian.
Treshchalina EM, Zhukova OS, Gerasimova GK, Andronova NV, Garin AM. Methodical recommendations on preclinical evaluation of antitumor activity of drugs. Manual for Preclinical Studies of Drugs. Part I. Mironov AN, ed. Moscow, 2013. P. 642-656. Russian.
Belska NV, Guriev AM, Danilets MG, Trophimova ES, Uchasova EG, Ligatcheva AA, Belousov MV, Agaphonov VI, Golovchenko VG, Yusubov MS, Belsky YP. Water-soluble polysaccharide obtained from Acorus calamus L. classically activates macrophages and stimulates Th1 response. Int. Immunopharmacol. 2010;10(8):933-942.
Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 2012;366(26):2455-2465.
Fuse H, Tomihara K, Heshiki W, Yamazaki M, Akyu-Takei R, Tachinami H, Furukawa K, Sakurai K, Rouwan M, Noguchi M. Enhanced expression of PD-L1 in oral squamous cell carcinoma-derived CD11b+Gr-1+cells and its contribution to immunosuppressive activity. Oral Oncol. 2016;59:20-29.
Patel SP, Kurzrock R. PD-L1 Expression as a predictive biomarker in cancer immunotherapy. Mol. Cancer Ther. 2015;14(4):847-856.
Patriarca C, Macchi RM, Marschner AK, Mellstedt H. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat. Rev. 2012;38(1):68-75.
Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl. Med. 2016;8(328):328rv4. doi: https://doi.org/10.1126/scitranslmed.aad7118.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 7, pp. 119-122, July, 2017
Rights and permissions
About this article
Cite this article
Lopatina, K.A., Safonova, E.A., Nevskaya, K.V. et al. Effect of Acorus calamus L. Polysaccharide on CD274 and CD326 Expression by Lewis Lung Carcinoma Cells in Mice. Bull Exp Biol Med 164, 102–105 (2017). https://doi.org/10.1007/s10517-017-3934-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-017-3934-4